Dec 06, 2022 / 07:00PM GMT
Operator
Good afternoon, and welcome to the Lumos Pharma KOL Event. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the Lumos website following the conclusion of the event.
I'd now like to turn the call over to Rick Hawkins, Chairman and Chief Executive Officer of Lumos Pharma. Please go ahead, Rick.
Richard J. Hawkins - Lumos Pharma, Inc. - CEO & Chairman
Thank you, Sarah, and good afternoon and thank you for joining us for our KOL event to review the interim data from our 2 Phase II trials evaluating oral LUM-201 in moderate idiopathic pediatric growth hormone deficiency. I'm Rick Hawkins, CEO and Chairman of Lumos Pharma and will be joined by 2 noted thought leaders in the field of pediatric endocrinology for our discussion.
Now before we proceed with our program, I'd like to remind everyone that certain statements made during this event are considered forward-looking statements under U.S. federal securities laws and the actual results may differ materially from historical experience or
Lumos Pharma Inc To Host KOL Webinar Transcript
Dec 07, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers